Determination of miloxacin and metabolites in human serum and urine by high-pressure liquid chromatography.
A sensitive and reliable high-pressure liquid chromatography (HPLC) assay for miloxacin and its two principal metabolites, 5,8-dihydro-8-oxo-2H-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid (M-1) and 1,4-dihydro-1,6-dimethoxy-7-hydroxy-4-oxoquinoline-3-carboxylic acid (M-2), in human serum and urine was developed. A strong anion-exchange Zipax SAX column using a mobile phase of 0.01 M citric acid solution containing 0.03 M sodium nitrate with pH 5.0 was used to achieve separation of the three compounds. The retention times of miloxacin, M-1, and M-2 were 3.8, 9.3, and 5.9 min, respectively. Serum and urine concentrations of these compounds as low as 10 ng/ml were measured. When results from the HPLC assay were compared with those from the microbiological assay of serum and urine samples from human subjects receiving miloxacin orally, the correlation coefficients were 0.94 for the serum and 0.99 for the urine. The HPLC assay method presents an alternative to the microbiological assay and permits future pharmacokinetic investigations of miloxacin.
D042462:4-Quinolones; D000890:Anti-Infective Agents / Q000032:analysis* / Q000097:blood / Q000652:urine; D001681:Biological Assay; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D006801:Humans; D006912:Hydroxyquinolines / Q000032:analysis; D008826:Microbial Sensitivity Tests; D010093:Oxolinic Acid / Q000031:analogs & derivatives* / Q000032:analysis / Q000097:blood / Q000652:urine; D012044:Regression Analysis
D042462:4-Quinolones; D000890:Anti-Infective Agents; D006912:Hydroxyquinolines; C026431:5,8-dihydro-8-oxo-2H-1,3-dioxolo(4,5-g)quinoline-7-carboxylic acid; C026432:1,4-dihydro-1,6-dimethoxy-7-hydroxy-4-oxoquinoline-3-carboxylic acid; D010093:Oxolinic Acid; C023981:miloxacin